Femoral veno-arterial extracorporeal life support with minimal or no heparin.

[1]  P. Wollmer,et al.  Venoarterial extracorporeal membrane oxygenation--how safe is it? Evaluation with a new experimental model. , 1992, The Journal of thoracic and cardiovascular surgery.

[2]  S. Steen,et al.  Twenty-four-hour heparin-free veno-right ventricular ECMO: an experimental study. , 1992, The Annals of thoracic surgery.

[3]  J. L. Rodriguez,et al.  Early experience with adult extracorporeal membrane oxygenation in the modern era. , 1992, The Annals of thoracic surgery.

[4]  E. Fosse,et al.  Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. , 1992, The Journal of thoracic and cardiovascular surgery.

[5]  P. Venge,et al.  Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass. , 2008, Artificial organs.

[6]  S. Steen,et al.  Pulmonary sequelae of prolonged total venoarterial bypass: evaluation with a new experimental model. , 1991, The Annals of thoracic surgery.

[7]  R H Bartlett,et al.  Extracorporeal life support for cardiopulmonary failure. , 1990, Current problems in surgery.

[8]  L. Cohn,et al.  Reoperative Cardiac Surgery Using A New Femoral Venous Right Atrial Cannula , 1990, Journal of cardiac surgery.

[9]  M. Turina,et al.  Superior hemodynamics in left heart bypass without systemic heparinization. , 1990, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[10]  C. Geisen,et al.  Heparin free long-term extracorporeal circulation using bioactive surfaces. , 1989, ASAIO transactions.

[11]  S. Salley,et al.  Quantitative scanning electron microscopy for the evaluation of thrombosis in extracorporeal circuits. , 1988, ASAIO transactions.

[12]  R. Rossaint,et al.  Extracorporeal CO2-removal with a heparin coated artificial lung , 1988, Intensive Care Medicine.

[13]  R. Larsson,et al.  A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. , 1983, Biomaterials, medical devices, and artificial organs.

[14]  Rupert G. Miller,et al.  Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. , 1979, JAMA.

[15]  J. Crapo,et al.  Pulmonary morphology in a multihospital collaborative extracorporeal membrane oxygenation project. I. Light microscopy. , 1979, The American journal of pathology.

[16]  J J Osborn,et al.  Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. , 1972, The New England journal of medicine.

[17]  G. Schmer.  THE BIOLOGICAL ACTIVITY OF COVALENTLY IMMOBILIZED HEPARIN , 1972, Transactions - American Society for Artificial Internal Organs.

[18]  R. Dutton,et al.  Heparin Bonding on Colloidal Graphite Surfaces , 1963, Science.